278. Huge lymphatic malformation with cervicofacial lesion
19 clinical trials, 23 drugs (DrugBank: 7 drugs), 5 drug target genes, 62 drug target pathways
Searched query = "Huge lymphatic malformation with cervicofacial lesion", "Huge lymphatic malformation", "Lymphatic malformation"
The queries were searched in Public_title, Scientific_title, and Condition. Export date: 03/15/2021. Trials are sorted by Date_enrollment from most recent to oldest in the table.
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | NCT04409145 (ClinicalTrials.gov) | October 1, 2020 | 11/5/2020 | First in Human Trial of Topical VT30 in Pts With Venous/Lymphatic Malformations Assoc With PIK3CA or TEK Gene Mutations | Open-Label, Intra Subject, Dose Escalation (Part 1) Followed by Randomized, Double Blind, Placebo Controlled (Part 2) Trial of Topical VT30 in Pts With Venous, Lymphatic or Mixed Malformations Associated With PIK3CA or TEK Genetic Mutations | Venous Malformation;Lymphatic Malformation;Venolymphatic Malformation | Drug: VT30 | Venthera, Inc. | NULL | Recruiting | 18 Years | 60 Years | All | 51 | Phase 1;Phase 2 | United States |